Breaking News

You are here » Indian-Commodity  :  Commodities  :  Poor Cardamom Costs Consistent With Fundamentals

14-May2011

Poor Cardamom Costs Consistent With Fundamentals

Having a bumper harvesting and carry-over stocks even now in stores, there is also a sales force related to cardamom that is maintaining the regional deals estimating rates at Rs.700/kg.

Specific press states estimating Spice Panel declared cardamom sector continues to be seeing a contradiction where in spite of a strong requirement in the offing, industry were watching a slip. The statement quoted the Spice Panel as stating that the sell rates show a drop previously couple of days with out enough causes.

It is a common cost for cardamom. said a respected Kochi-based broker.Of course there was occasions when the cardamom costs rose to Rs.1500/kg creating trading a dangerous affair. However which was unusual. We would suggest Rs.800-900 scale a great cost... he put in.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......